These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7834325)

  • 21. Release of peptide leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatics.
    Picado C; Ramis I; Rosellò J; Bulbena O; Plaza V; Gelpi E
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():501-2. PubMed ID: 1825369
    [No Abstract]   [Full Text] [Related]  

  • 22. [Asthma and aspirin].
    Schiappoli M; Gani F; Frati F; Marcucci F; Senna G
    Recenti Prog Med; 2003 Feb; 94(2):79-87. PubMed ID: 12908375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.
    Szczeklik A; Sladek K; Dworski R; Nizankowska E; Soja J; Sheller J; Oates J
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1608-14. PubMed ID: 8970343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma.
    Nasser SM; Patel M; Bell GS; Lee TH
    Am J Respir Crit Care Med; 1995 May; 151(5):1326-30. PubMed ID: 7735581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of aspirin-intolerant asthma: identifying inflammatory pathways in the pathogenesis of asthma.
    Neighbour H
    Int Arch Allergy Immunol; 2014; 163(1):1-2. PubMed ID: 24247362
    [No Abstract]   [Full Text] [Related]  

  • 26. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
    Pfaar O; Klimek L
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased excretion of leukotriene E4 during aspirin-induced asthma.
    Knapp HR; Sladek K; Fitzgerald GA
    J Lab Clin Med; 1992 Jan; 119(1):48-51. PubMed ID: 1309376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
    Schapowal AG; Simon HU; Schmitz-Schumann M
    Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interleukin-5 in aspirin-induced asthma.
    Mastalerz L; Sanak M; Szczeklik A
    Clin Exp Allergy; 2001 Jul; 31(7):1036-40. PubMed ID: 11467994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physiopathology of asthma: what role for leukotrienes?].
    Lockhart A; Dinh-Xuan AT
    Rev Pneumol Clin; 1997; 53(3):119-27. PubMed ID: 9296112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of leukotrienes in asthma.
    Henderson WR
    Ann Allergy; 1994 Mar; 72(3):272-8. PubMed ID: 8129221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible mechanisms underlying mucus secretion in aspirin-sensitive asthma.
    Kaliner M; Marom Z
    J Asthma; 1983; 20 Suppl 1():9-13. PubMed ID: 6408056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics.
    Schäfer D; Schmid M; Göde UC; Baenkler HW
    Eur Respir J; 1999 Mar; 13(3):638-46. PubMed ID: 10232440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin-sensitive rhinosinusitis and asthma.
    Kowalski ML
    Clin Allergy Immunol; 2007; 19():147-75. PubMed ID: 17153012
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements.
    Pfaar O; Klimek L
    Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):161-6. PubMed ID: 16670507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients.
    Kowalski ML; Pawliczak R; Wozniak J; Siuda K; Poniatowska M; Iwaszkiewicz J; Kornatowski T; Kaliner MA
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):391-8. PubMed ID: 10673176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge.
    Juergens UR; Christiansen SC; Stevenson DD; Zuraw BL
    J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 1):636-45. PubMed ID: 1328344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism.
    Szczeklik A; Dworski R; Mastalerz L; Prokop A; Sheller JR; Nizankowska E; Cmiel A; Oates JA
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1168-72. PubMed ID: 9769277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediator assays in aspirin-induced asthma.
    Szczeklik A
    Allergy Proc; 1994; 15(3):135-8. PubMed ID: 7926712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.